Glaukos Corporation Announces Third Quarter 2021 Financial Results
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
Year: 2021
Inogen Announces Third Quarter 2021 Financial Results
– Q3 2021 Total Revenue increased 25.3% from the same period in 2020 to $93.1 million – GOLETA, Calif.--(BUSINESS WIRE)--Inogen,...
Covetrus Announces Financial Results for Third Quarter of 2021
Third quarter GAAP net sales of $1.16 billion, an increase of 3% year-over-year; non-GAAP organic net sales increased 3% year-over-year...
Axonics® Reports Third Quarter 2021 Financial Results
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
Unum Vaccine Verifier™ Helps Employers Meet Federal Requirements
CHATTANOOGA, Tenn., Nov. 4, 2021 /PRNewswire/ -- Unum Vaccine Verifier™ is now available to help employers navigate the new COVID-19 vaccine...
MorphoSys Presents Interim Results from M-PLACE Study with Felzartamab during American Society of Nephrology Annual Meeting
Felzartamab has the potential to rapidly and substantially reduce anti-PLA2R antibody titers in patients with anti-PLA2R-positive membranous nephropathyPLANEGG/MUNICH, GERMANY /...
Biotricity Releases Fiscal 2022 Second Quarter Financial Results
Company reports tenth consecutive quarter of triple-digit year-over-year revenue growthStrongest balance sheet since inceptionREDWOOD CITY, CA / ACCESSWIRE / November...
ReCor Medical Reports Latest Data from Landmark Renal Denervation Clinical Trials at TCT Annual Meeting
RADIANCE-HTN TRIO and SOLO trial updates demonstrate the durability of blood pressure lowering effects of the Paradise Ultrasound Renal Denervation...
Kerri Swope Joins ESO as Chief Customer Officer
Swope brings years of experience leading customer-centric organizations AUSTIN, Texas--(BUSINESS WIRE)--ESO, the leading data and software company serving emergency medical...
Cardiovascular Systems, Inc. Announces First In-Human Experience With Coronary Everolimus Drug Coated Balloon
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems...
Streamline’s SmartCare MCO Solution Goes Live for Two Additional Ohio Counties
OAKBROOK TERRACE, Ill.--(BUSINESS WIRE)--#EHR--The Delaware-Morrow Mental Health & Recovery Services Board has joined the PartnerSolutions county board collaborative and recently...
SupplySide West & Food ingredients North America Bring Together the Food & Beverage and Nutrition Industry to Re-Connect and Fuel Growth
Hybrid Event Pairs In-Person Trade Show with Virtual Offerings through SupplySide Network 365 to Provide Opportunities for Innovation Professionals to...
Silo Wellness Announces Corporate Updates
Toronto, Ontario--(Newsfile Corp. - November 4, 2021) - Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K70) ("Silo Wellness" or...
NextGen Healthcare Client Bridges Health Partners Achieves Medicare Savings of Nearly $30 Million with NextGen Population Health Solution
Clinically Integrated Network Leverages NextGen® Population Health Solutions to Improve Patient Care While Exceeding Its Savings Objectives for Three Consecutive...
Sparta Appoints, Aerospace and Space Health Experts, Mr. Michel Lortie & Mr. Sol Rauch, to its Technical Advisory Board
TORONTO, ON / ACCESSWIRE / November 4, 2021 / With COVID-19 affecting daily life in unprecedented ways, the demand for...
MorphoSys to Present MANIFEST and RE-MIND2 Data from Expanded Hematology-Oncology Portfolio at the 2021 American Society of Hematology (ASH) Annual Meeting
- Updates from MANIFEST phase 2 trial in patients with myelofibrosis, including clinical updates on JAK naïve patients treated with...
Kadmon Provides Business Update and Reports Third Quarter 2021 Financial Results
- REZUROCK™ (belumosudil) 200 mg once daily (QD) tablets are now commercially available for shipment to prescribed patients in the...
Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements
TORONTO, ON / ACCESSWIRE / November 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic...
NeoGenomics Reports Revenue of $121 Million in the Third Quarter
Third-Quarter 2021 Results and Highlights:Consolidated revenue of $121 million, comprised of Clinical Services revenue of $102 million and Pharma Services...
NeoGenomics Announces Leadership Team Transition
FT. MYERS, FL / ACCESSWIRE / November 4, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing...
